Aadel Chaudhuri: cfDNA epigenomics for early cancer and MRD detection
Aadel Chaudhuri shared on X:
“Happy holidays all!
… As you take some time to relax this holiday season, think of a great story you’d like to submit to the npj Journals
Precision Oncology issue I’m guest editing on cfDNA epigenomics for early cancer and MRD detection.”
Cell-free DNA epigenomics for early cancer and MRD detection
Aadel Chaudhuri, MD PhD is the Vice Chair of Translational Research in the Department of Radiation Oncology at Mayo Clinic. He is also a Visiting Associate Professor, in the Department of Computer Science and Engineering at the Washington University in St. Louis. His research focuses on the development and application of biofluid-based cell-free DNA technologies for solid tumor response assessment and molecular residual disease (MRD) detection.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023